(Q30702631)

26 June 2017

1 reference

title

Immunostimulating complexes (ISCOMs) for nasal vaccination (English)

1 reference

26 June 2017

Hu KF

1

1 reference

26 June 2017

Lövgren-Bengtsson K

series ordinal

2

1 reference

26 June 2017

Morein B

series ordinal

3

1 reference

26 June 2017

language of work or name

English

0 references

publication date

1 September 2001

1 reference

Advanced Drug Delivery Reviews

26 June 2017

1 reference

26 June 2017

51

1 reference

26 June 2017

149-159

1 reference

26 June 2017

1-3

1 reference

New strategies for using mucosal vaccination to achieve more effective immunization

26 June 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Cholera toxin and cholera B subunit as oral-mucosal adjuvant and antigen vector systems

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Preservation of mucosal and systemic adjuvant properties of ISCOMS in the absence of functional interleukin-4 or interferon-gamma.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Functional aspects of iscoms

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Iscom, a novel structure for antigenic presentation of membrane proteins from enveloped viruses.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Antiviral response elicited by a completely synthetic antigen with built-in adjuvanticity

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Quaternary structure of the immunostimulating complex (iscom).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Immune response to immunostimulatory complexes (ISCOMs) prepared from human immunodeficiency virus type 1 (HIV-1) or the HIV-1 external envelope glycoprotein (gp120).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

The iscom: an immunostimulating system

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

ISCOMs and immunostimulation with viral antigens

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Iscom and iscom-matrix enhance by intranasal route the IgA responses to OVA and rCTB in local and remote mucosal secretions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

ISCOMs and other saponin based adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

ISCOMs: an adjuvant with multiple functions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Iscoms with different quillaja saponin components differ in their immunomodulating activities

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Interactions between Immune-Stimulating Complexes (ISCOMs) and Peritoneal Mononuclear Leucocytes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Antigen-specific increases in the number of splenocytes expressing MHC class II molecules following restimulation with antigen in various physical forms.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

The induction of cell-associated and secreted IL-1 by iscoms, matrix or micelles in murine splenic cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

In vivo and in vitro induction of IL-6 by Quillaja saponaria molina triterpenoid formulations

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Immunomodulation by Quillaja saponaria adjuvant formulations: in vivo stimulation of interleukin 12 and its effects on the antibody response

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Adjuvant activity of iscoms; effect of ratio and co-incorporation of antigen and adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Kinetics, localization and cytokine profile of T cell responses to immune stimulating complexes (iscoms) containing human influenza virus envelope glycoproteins

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Effect of iscoms and their adjuvant moiety (matrix) on the initial proliferation and IL-2 responses: comparison of spleen cells from mice inoculated with iscoms and/or matrix.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Involvement of interleukin-2 and interferon-gamma in the immune response induced by influenza virus iscoms

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Induction of Th1 and Th2 CD4+ T cell responses by oral or parenteral immunization with ISCOMS.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Iscoms Containing PurifiedQuillajaSaponins Upregulate both Th1-like and Th2-like Immune Responses

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Immune responses in mice induced by HSV-1 glycoproteins presented with ISCOMs or NISV delivery systems

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Influence of Quillaja saponaria triterpenoid content on the immunomodulatory capacity of Epstein-Barr virus iscoms

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Internalization of iscom-borne antigens and presentation under MHC class I or class II restriction

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Induction of CD8+ cytotoxic T cells by immunization with purified HIV-1 envelope protein in ISCOMs

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Cellular immune responses in the murine lung to local immunization with influenza A virus glycoproteins in micelles and immunostimulatory complexes (iscoms).

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Antigen presentation by naive macrophages, dendritic cells and B cells to primed T lymphocytes and their cytokine production following exposure to immunostimulating complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Comparison of immunity generated by nucleic acid-, MF59-, and ISCOM-formulated human immunodeficiency virus type 1 vaccines in Rhesus macaques: evidence for viral clearance.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

ISCOM: a delivery system for neonates and for mucosal administration

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

An experimental influenza subunit vaccine (iscom): induction of protective immunity to challenge infection in mice after intranasal or subcutaneous administration

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Characterization of immunomodulatory properties and accessory cell function of small intestinal epithelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Secretory immune responses in the mouse vagina after parenteral or intravaginal immunization with an immunostimulating complex (ISCOM)

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Challenges for vaccination against sexually-transmitted diseases: induction and long-term maintenance of mucosal immune responses in the female genital tract

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Manipulating systemic and mucosal immune responses with skin-deliverable adjuvants

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

ISCOMS — a novel strategy for mucosal immunization?

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Oral vaccination with immune stimulating complexes.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

The mucosal adjuvant effects of cholera toxin and immune-stimulating complexes differ in their requirement for IL-12, indicating different pathways of action

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Induction of systemic and mucosal immune responses following immunization with somatostatin-avidin complexes incorporated into ISCOMS

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Chimeric plant virus particles administered nasally or orally induce systemic and mucosal immune responses in mice.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Intranasal immunization of mice with Echinococcus granulosus surface antigens iscoms evokes a strong immune response, biased towards glucidic epitopes.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Initiation of cytotoxic T-cell response and protection of Balb/c mice by vaccination with an experimental ISCOMs respiratory syncytial virus subunit vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

The immunostimulating complex (ISCOM) is an efficient mucosal delivery system for respiratory syncytial virus (RSV) envelope antigens inducing high local and systemic antibody responses

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

A mucosal IgA response, but no systemic antibody response, is evoked by intranasal immunisation of dogs with Echinococcus granulosus surface antigens iscoms

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Control of infectious bovine rhinotracheitis in calves with a BHV-1 subunit-ISCOM vaccine

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Influenza virus ISCOMs: antibody response in animals

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Influenza virus ISCOMs: biochemical characterization

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Characterization of immunostimulating complexes (ISCOMS) of HIV-1.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Responses of ponies to equid herpesvirus-1 ISCOM vaccination and challenge with virus of the homologous strain.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Induction of feline leukaemia virus-neutralizing antibodies by immunization with synthetic peptides derived from the FeLV env gene

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Characterization of purified gp 51 from bovine leukemia virus integrated into iscom. Physicochemical properties and serum antibody response to the integrated gp51.

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Immunity against parainfluenza-3 virus in cattle. IgA in nasal secretions

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Mucosal and systemic antibody responses after peroral or intranasal immunization: effects of conjugation to enterotoxin B subunits and/or of co-administration with free toxin as adjuvant

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Induction of antibody responses in the common mucosal immune system by respiratory syncytical virus immunostimulating complexes

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

Influenza (H1N1)-ISCOMs enhance immune responses and protection in aged mice

1 reference

https://api.crossref.org/works/10.1016%2FS0169-409X%2801%2900165-X

7 January 2021

10.1016/S0169-409X(01)00165-X

Identifiers

DOI

1 reference

26 June 2017

1 reference